Obestatin signalling counteracts glucocorticoid‐induced skeletal muscle atrophy via NEDD4/KLF15 axis

• Main Authors: Tania Cid‐Díaz (Author), Saúl Leal‐López (Author), Fátima Fernández‐Barreiro (Author), Jessica González‐Sánchez (Author), Icía Santos‐Zas (Author), Luis J. Andrade‐Bulos (Author), Manuel E. Rodríguez‐Fuentes (Author), Carlos S. Mosteiro (Author), Vincent Mouly (Author), Xesús Casabiell (Author), Jose Luis Relova (Author), Yolanda Pazos (Author), Jesus P. Camiña (Author)
• Format: Book
• Published: Wiley, 2021-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background A therapeutic approach for the treatment of glucocorticoid‐induced skeletal muscle atrophy should be based on the knowledge of the molecular mechanisms determining the unbalance between anabolic and catabolic processes and how to re‐establish this balance. Here, we investigated w...